Stockreport

Ensho Therapeutics Launches with Phase 2-Ready Oral a4ß7 Inhibitor for Inflammatory Bowel Disease [Yahoo! Finance]

Biogen Inc.  (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
PDF Seasoned Executive Team with History of Execution in Inflammatory Bowel Disease Drug Development to Join Ensho on July 1 Founded by Neena Bitritto-Garg, Veteran Bio [Read more]